Debiopharm ( a privately-owned, Swiss-based biopharmaceutical company aiming to establish tomorrow’s standard-of-care to cure cancer and infectious diseases and develop new antibody linker ...

STOCKHOLM, SE / ACCESS Newswire / April 23, 2025 / Vicore Pharma Holding (STO:VICO)Stockholm, April 23, 2025 - Vicore Pharma Holding AB (STO: VICO), unlocking the potential of a novel class of drugs, ...

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that two oral presentations and a poster presentation featuring data for the company’s NeXT ...

PathAI, a global leader in AI-powered pathology solutions, today announced it will present research from the outputs of PathAI's pathology universal transformer (PLUTO) foundation model and portfolio ...

AP Biosciences, a clinical-stage biopharmaceutical company dedicated to transforming cancer therapy through innovative bispecific antibodies, today announced that it will present a preclinical ...

Abstracts are available on the EASL Congress 2025 website at https://www.easlcongress.eu/. The posters are expected to be ...

Twenty-six student members of Minorities in Agriculture, Natural Resources and Related Sciences participated in the 39th National MANRRS Conference, with four earning top places in graduate student ...

The Summit brings together Fortune 500 leaders, entrepreneurs, and sustainability experts to create a more vibrant, equitable ...

Adobe Express features can really help with visual communication, such as Generate Template, offering a library of thousands ...

Penn State Altoona Chancellor Ron Darbeau listens to an explanation of research conducted by students Layna Henry, Minjoo Kim ...

I am excited to update you on our overall strategy, progress, and key priorities and goals for 2025. Strategic Overview and ...